Herniaty Rampo, Uleng Bahrun, Mansyur Arif


HIV-TB co-infection is a global challenge in the healthcare world. HIV infection causes CD4  to decrease which has a role in TB immunity. CD4 as a marker for HIV progression have expensive cost and not available in all healthcare facilities, so WHO recommended TLC as a substitute for CD4. This study aims to determine the correlation of TLC and CD4 in HIV-TB co-infection patients.This was a retrospective study using medical records of hospitalized patients with HIV-TB co-infection in Dr.Wahidin Sudirohusodo Hospital. The correlation was analyzed by Spearman test. CD4 data were divided into two groups: CD4 < 200 cells/mm3 and CD4 ≥ 200 cells/mm3 and Mann-Whitney test was performed. Data were also analyzed by ROC curve.In total 172 data with diagnosis of HIV-TB co-infection, Spearman test showed a positive correlation between TLC and CD4  with moderate correlation strength (p <0.001 and r = 0.56). Mann-Whitney test showed  a significant difference between CD4 < 200 cells/mm3 and CD4 ≥ 200 cells/mm3 (p < 0.001). ROC curve analysis showed that TLC has a good accuracy value for predicting CD4 in CD4 < 200 cells/mm3 (AUC = 0.911). Sensitivity  88.9% with specificity 84.7% was found in TLC 1154.9 cells/mm3 which predicted CD4  < 200 cells/mm3.There was a positive correlation between TLC and CD4 with moderate correlation strength. TLC can predict CD4 in CD4 <200 cells/mm3. We suggest further studies on patients who receive drug therapy.


HIV-TB co-infection, TLC, CD4

Full Text:



World Health Organization. Global HIV Statistics. 2016 [cited at May 10,2017]. Available at :

World Health Organization. Global Tuberculosis report. 2016 [cited at May 10, 2017]. Available at :

Baratawidjaja KG. Defisiensi Imun dalam Imunologi Dasar. EdisiKe-11. Jakarta: Badan Penerbit FKUH. 2014: 449-57.

WHO. Guidlines for HIV Diagnosis and Monitoring of Antiretroviral Therapy.[cited at May 4,2017]. Available at :

Alavi SM, Ahmadi F, Farhadi M. Correlation between Total Lymphocyte Count, Hemoglobin, Hematocrit and CD4 Count in HIV/AIDS Patients. Acta Medica Iranica. 2009;47(1):1-4.

Sen LCS, Vyas A, Sanghi LCS, et al. Correlation of CD4+ T cell Count with Total Lymphocyte Count Haemoglobin and Erythrocyte Sedimentation Rate Levels in Human Immunodeficiency Virus Type-1 Disease. MJAFI.2011;67:15-20.

Angelo ALD, Angelo CD, Torres AJL, et al. Evaluating Total Lymphocyte Counts as a Substitute for CD4 Counts in the Follow Up of AIDS Patients. BJID.2007:11(5);466-70.

Kumarasamy N, Mahajan AP, Flanigan TP, et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India a nd other resource-constrained countrie, J Acquir Immune Defic Syndr , 2002, vol. 31 (pg. 378-83)

Blatt SP, LuceyCR, ButzinCA, et al. . Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected person, JAMA, 1993, vol. 269 (pg. 622-6)

Martin DJ, Sim JGM, Sole GJ, et al. CD4+ lymphocyte count in African patients coinfected with HIV and tuberculosis. J Acquir Immune Defic Syndr Human Retrovirol 1995;8:386-91.



  • There are currently no refbacks.